| Literature DB >> 31357635 |
Cheng Chi1, Sib Sankar Giri2, Jin Woo Jun3, Hyoun Joong Kim2, Saekil Yun2, Sang Wha Kim2, Jeong Woo Kang2, Se Chang Park4.
Abstract
Thiazolidinedione 49 (TD49), a newly synthesized algicide, shows strong toxicity at low concentrations of 0.1-2.0 μM. However, its potential effects on non-target species at the transcript level were not investigated. Differentially expressed genes (DEGs) in the gills of the bay scallop, Argopecten irradians, were accessed after treatment with 0.68 μM TD49 for up to 48 h. Following exposure, it was observed that 5214 genes were upregulated and 3497 were downregulated. Functional enrichment analysis revealed that the apoptosis pathway was activated. The extrinsic apoptosis pathway was activated and the survival factors related pathway was suppressed. Furthermore, gene expressions related to ATP-binding cassette, nuclear factor erythroid 2-related factor, B cell lymphoma-2 family protein, glutathione reductase, glutathione peroxidase, catalase, NADPH2:quinone reductase, and superoxide dismutase were decreased. Conversely, gene expressions related to FAS-associated death domain protein, glutathione S-transferase, caspase 6, 8, cytochrome P450 1A1, and 2C8 were increased. These results comprehensively demonstrated the toxicity of the novel algicide TD49, and should draw the attention of researchers to the importance of analyzing the potential impact of chemical compounds as algicides to control the proliferation of harmful algae, due to the secondary pollution caused by their application.Entities:
Keywords: Thiazolidinedione 49; algicide; apoptosis; bay scallop; detoxification; immunity; transcriptomic analysis
Mesh:
Substances:
Year: 2019 PMID: 31357635 PMCID: PMC6722943 DOI: 10.3390/biom9080310
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Summary of sequencing reads after filtering.
| Sample | Total Raw Reads (Mb) | Total Clean Reads (Mb) | Total Clean Bases (Gb) | Clean Reads Q20 (%) | Clean Reads Q30 (%) | Clean Reads Ratio (%) |
|---|---|---|---|---|---|---|
| CN | 45.92 | 45.76 | 4.58 | 98.21 | 95.30 | 99.65 |
| TD | 45.92 | 45.85 | 4.58 | 98.30 | 95.52 | 99.84 |
Q20: the rate of bases with a quality of greater than 20, CN: control, TD: Thiazolidinedione 49-exposed.
Quality metrics of transcripts.
| Sample | Total Number | Total Length | Mean Length | N50 | N70 | N90 | GC (%) |
|---|---|---|---|---|---|---|---|
| CN | 78,376 | 52,817,747 | 673 | 1231 | 568 | 252 | 39.12 |
| TD | 71,899 | 45,492,111 | 632 | 1093 | 518 | 245 | 39.23 |
N50: a weighted median statistic showing that ≥50% of the total length is contained in the transcripts, GC (%): the percentage of G and C bases in all transcripts, CN: control, TD: Thiazolidinedione 49-exposed.
Quality metrics of unigenes.
| Sample | Total Number | Total Length | Mean Length (bp) | N50 | N70 | N90 | GC (%) |
|---|---|---|---|---|---|---|---|
| CN | 51,394 | 40,985,988 | 797 | 1410 | 702 | 302 | 39.48 |
| TD | 48,654 | 36,217,952 | 744 | 1266 | 637 | 288 | 39.54 |
| All-unigene | 57,882 | 50,329,144 | 869 | 1594 | 827 | 321 | 39.36 |
N50: a weighted median statistic indicating that ≥50% of the total length is contained in the unigenes, GC (%): the percentage of G and C bases in all unigenes, CN: control, TD: Thiazolidinedione 49-exposed.
Figure 1Distribution of annotated species.
Summary of functional annotation of unigenes.
| Values | Total | Nr- | Nt- | SwissProt- | KEGG- | COG- | Interpro- | GO- | Overall |
|---|---|---|---|---|---|---|---|---|---|
| Number | 57,882 | 25,267 | 9983 | 19,555 | 18,931 | 8729 | 19,017 | 4032 | 28,172 |
| Percentage | 100% | 43.65% | 17.25% | 33.78% | 32.71% | 15.08% | 32.85% | 6.97% | 48.67% |
Figure 2Functional distribution of Clusters of Orthologous Groups (COG) annotation.
Figure 3Volcano plot of differentially expressed genes (DEGs) between the control (CN) and Thiazolidinedione (TD)-treated groups.
Figure 4M (log ratio) and A (mean average) (MA) plot of DEGs between the control (CN) and the Thiazolidinedione (TD)-treated group.
Figure 5Pathway classification of differentially expressed genes.
Figure 6Pathway classification of differentially expressed genes.
Figure 7Pathway functional enrichment of differentially expressed genes. Colors indicate q-value (high: white, low: blue), a lower q-value indicates more significantly enriched genes. The size of the dots indicates the degree of differential expression.
Figure 8Differentially expressed genes associated with apoptosis pathways. Red, green, and white boxes indicate significantly upregulated, downregulated, and unchanged expression in the transcriptomic profile, respectively.
Figure 9Differentially expressed genes associated with the p53 signaling pathway. Red, green, and white boxes indicate significantly upregulated, downregulated, and unchanged expression in the transcriptomic profile, respectively.
Detoxification, apoptosis, and immune-related differentially expressed genes in gills of bay scallop exposed to Thiazolidinedione 49 (TD49) for up to 48 h.
| Description | Transcript | Log2 Fold Change (RNAseq) | Regulation |
|---|---|---|---|
| Downregulated | |||
| Immune system | CLEC 4M | −1.62 | Down |
| CLEC 4F | −2.69 | Down | |
| FIBCD 1 | −2.00 | Down | |
| ACP 5 | −2.94 | Down | |
| ACP 6 | −2.40 | Down | |
| PAPL | −1.27 | Down | |
| HSP70 | −2.00 | Down | |
| Apoptosis | Bcl-2 | −1.90 | Down |
| BIRC 2 | −2.51 | Down | |
| BIRC 3 | −4.97 | Down | |
| BIRC 6 | −4.25 | Down | |
| BIRC 7A | −1.33 | Down | |
| BIRC 7B | −1.61 | Down | |
| Transmembrane proteins | ABC A3 | −5.01 | Down |
| ABC A5 | −2.80 | Down | |
| ABC B1 | −2.11 | Down | |
| ABC B10 | −4.27 | Down | |
| ABC C1 | −1.16 | Down | |
| ABC D3 | −1.32 | Down | |
| ABC G2 | −1.95 | Down | |
| Antioxidant system | NQO1 | −5.10 | Down |
| CAT | −3.06 | Down | |
| Mn SOD | −1.30 | Down | |
| Cu/Zn SOD | −1.56 | Down | |
| GR | −5.08 | Down | |
| GPx | −2.55 | Down | |
| Nrf2 | −1.61 | Down | |
| Metabolism of xenobiotics | CREBP 3 | −1.39 | Down |
| MOA | −1.79 | Down | |
| NOX3 | −1.55 | Down | |
| GSTω | −11.18 | Down | |
| Upregulated | |||
| Apoptosis | Cas3 | 2.29 | Up |
| Cas6 | 2.79 | Up | |
| FADD | 1.68 | Up | |
| Immune system | TLR 2 | 4.18 | Up |
| TRAF 6 | 1.17 | Up | |
| Metabolism of xenobiotics | CYP 1A1 | 2.45 | Up |
| CYP 2C8 | 8.52 | Up | |
| GST | 8.40 | Up | |
| GST 1 | 3.08 | Up | |
| GST | 3.20 | Up | |
| GST A | 3.41 | Up | |
| GST | 1.74 | Up |
CLEC: C-type lectin domain family, FIBCD: Fibrinogen C domain-containing protein, TLR: Toll-like receptor, ACP: Lysosomal acid phosphatase, PAPL: Iron/zinc purple acid phosphatase, ABC: ATP-binding cassette sub-family, CAT: Catalase, GR: Glutathione reductase, GST: Glutathione S-transferase, GPx: glutathione peroxidase, Bcl-2: B cell lymphoma-2 family protein, CREBP: Cyclic AMP-responsive element-binding protein, CYP: Cytochrome P450, Nrf2: Nuclear factor erythroid 2-related factor 2, NQO1: NAD(P)H:quinine oxidoreductase 1, NOX3: NADPH oxidase 3, BIRC: Baculoviral IAP repeat-containing protein, FADD: FAS-associated death domain protein, Cas: caspase, TRAF: tumor necrosis factor receptor-associated factor, MOA: flavin-containing monoamine oxidase A, HSP70: Heat shock protein 70, SOD: superoxide dismutase.
Figure 10Results of quantitative real time PCR (qPCR) validation (blue) compared to digital gene expression (DGE) analysis results (red). Data represent mean ± SD values (n = 3). GST-Kappa: glutathione-S-transferase Kappa, HSP70: Heat Shock Protein 70, MOA: monoamine oxidase A, Nrf2: Nuclear factor erythroid 2-related factor 2, NQO1: NAD(P)H:quinine oxidoreductase 1, ACP: acid phosphatase, CAT: catalase, NOX3: NADPH oxidase 3, SOD: superoxide dismutase.